Focused Alpha’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.59M Hold
4,205
– – 0.4% 48
2026
Q2
$1.23M Buy
4,205
+3
+0.1% +$851 0.32% 66
2026
Q1
$1.17M Sell
4,202
-1
-0% -$288 0.36% 52
2025
Q4
$1.27M Buy
+4,203
New +$1.31M 0.37% 50

Other funds holding BIO

Focused Alpha's BIO Position: Q3 2026 in Review

Focused Alpha held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 4,205 shares worth $1.59M. The position accounts for 0.4% of the portfolio, ranked #48.

Focused Alpha first reported a position in BIO in Q4 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Focused Alpha held 4,205 shares of Bio-Rad Laboratories Class A worth $1.59M as of Q3 2026.
  • Focused Alpha left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
  • Bio-Rad Laboratories Class A made up 0.4% of Focused Alpha's portfolio in Q3 2026, its #48 holding.
  • Focused Alpha first reported a position in Bio-Rad Laboratories Class A in Q4 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.